Eric Dube : The Accelerated Approval Pathway
... i'm eric debay president and ceo of trevere therapeutics we're a biopharmaceutical company exclusively focused on identifying ...
President and Chief Executive Officer, Travere Therapeutics, Inc.
Search every verified Eric Dube interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Eric Dube, president and CEO of Travere Therapeutics (formerly Retrophin), has spoken publicly about the company’s focus on rare diseases and its efforts to address health inequities. In interviews and company materials, Dube described himself as a two-time rare cancer survivor and emphasized that his personal experience informs his work. He stated that the company prioritizes patient-centered decision-making, inclusion, and diversity, and he discussed the need to reduce barriers to diagnosis, clinical trials, and treatment for underserved communities, including African American and Latinx patients affected by conditions such as FSGS. Dube also highlighted collaborative initiatives, including the creation of the Rare Disease Diversity Coalition in partnership with the Black Women’s Health Imperative, which he said involves about 40 leaders from rare disease and healthcare organizations. He advocated for faster clinical trial design and regulatory collaboration to bring innovation to rare kidney diseases, and he called for industry-wide cooperation to change the treatment landscape. His remarks were made in the context of his recognition as a 2020 PharmaVOICE 100 honoree.
... i'm eric debay president and ceo of trevere therapeutics we're a biopharmaceutical company exclusively focused on identifying ...
Meet Retrophin Inc.'s CEO and President, Eric Dube, PhD. Eric is a results-driven leader who is committed to patients and integrating their perspective into all aspects of the company’s operations. At Retrophin, Eric oversees a global team of more than 225 employees who are dedicated to identifying, developing and delivering life-changing therapies to people living with rare disease, as well as the advancement of the company’s promising pipeline featuring an innovative product candidate with first-in-class potential.
Eric Dube, Retrophin, talks about rare disease, equity, diversity, and inclusion.
Sign in to search the full transcript archive, filter by topic, and access every quote from Eric Dube.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →
Pro unlocks every transcript in full, plus unlimited search across every executive and company we cover.
50% off appliedPulling data at scale? The Data API gives you 30,000 transcripts a month over REST, MCP and JSON.
Compare all plans